| Peer-Reviewed

Quality of Life and Urinary Disorders in Metabolic Syndrome

Received: 13 June 2014     Accepted: 9 August 2014     Published: 20 August 2014
Views:       Downloads:
Abstract

Introduction: Risk factors of urinary disorders in metabolic syndrome are known. Effect of their association is poorly documented. Objectives: Determine the types of metabolic syndrome as a largest provider of urinary disorders and impact of these on the quality of life. Methodology: We conducted a cross-sectional, descriptive, analytical multicenter study from january to May 2013. It was done in three centers: the departments of Physical Medicine and endocrinology of university hospital Ibn Rochd of Casablanca and the Lions Club’s "Insulin bank" of Cotonou, Benin. All patients with metabolic syndrome were included. Metabolic syndrome was diagnosed for NCEP ATP III criteria. Variables such as demographic characteristics, metabolic syndrome, glycemia, triglyceridemia and HDL cholestrolemia were noted. Evaluation of Urinary disorder was conducted by Urinary Symptoms Profile scale (USP). Urinary Symptoms Profile scale has ten items. It accesses urinary incontinence, urge incontinence and dysuria. Evaluation of quality of life was conducted by SF Qualiveen Scale. SF Qualiveen evaluates bother with limitations, fears, feeling and frequency of limitations. Results: we included 68 patients. Women represented 82.2%. The mean of age was 54.43 years. Patients with diabetes represented 98.5%. The main types of metabolic syndrome were the following associations: diabetes, high blood pressure and obesity (19.1%); diabetes, high blood pressure and dyslipidemia (16.2%); diabetes, obesity and dyslipidemia (8.8%). Urinary disorders are reported in 51.5% of cases. The main urinary symptoms were overactive bladder (58.8%), urinary incontinence (32.4%) and dysuria (16.2%). Overactive bladder was found in 64.28% of women and in 50% of men. Forty seven point thirty six percent (47.36%) of patients with diabetic neuropathy have manifested dysuria. The average score of USP was 8+/- 8.8. The average score of Qualiveen was 1.25. Metabolic syndrome is significantly associated to urinary disorders, especially the types diabetes-obesity-dyslipidemia (p=0.004) and diabetes-obesity- high blood pressure (HBP) p=0.001). Discussion: Urinary disorders in metabolic syndrome are dominated for overactive bladder. Overactive bladder is more frequent in women and patients aged less than 40 years. Risk factors of urinary disorder are diabetes and obesity. In metabolic syndrome, quality of life is impaired in patients with urinary disorders. Conclusion: Metabolic syndrome, especially the associations diabetes-obesity and diabetes- high body circumference (HBC) to others items, increased risk of urinary disorders. Urinary symptoms in metabolic syndrome are dominated by overactive bladder. Overactive bladder is more frequent in women and patients aged less than 40 years. Dysuria is unusual in metabolic syndrome and it’s not always correlated to diabetic neuropathy. Quality of life is impaired in patients with urinary disorder.

Published in American Journal of Biomedical and Life Sciences (Volume 2, Issue 4)
DOI 10.11648/j.ajbls.20140204.13
Page(s) 78-82
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2014. Published by Science Publishing Group

Keywords

Metabolic, Syndrome, Urinary, Disorder

References
[1] Stern MP, Williams K, González-Villalpando C, Hunt KJ, Haffner SM . Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care. 2004; 27: 2676-2681.
[2] Allal-Elasmi M, Haj Taieb S, Hsairi M, Zayani Y, Omar S, San-Haji H et al. The metabolic Syndrome: Prevalence main characteristics and association with socio-economic status in adults living in Great Tunis. Diabetes Metab 2010; 36: 204-8.
[3] Golden S H, Robinson K A, Saldanha I, Anton B, Ladenson P W. Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab 2009; 94: 1853-78.
[4] Rohrmann S, Smit E, Giovannucci E, Platz E A. The association between markers of the metabolic syndrome and lower urinary tract symptoms in the third National Health and Nutrition Examination Survey (NHANES III). Int J Obes (Lond) 2005; 29: 310-6.
[5] Uzun H, Zorba OÜ. Metabolic syndrome in female patients with overactive bladder. Urology 2012; 79: 72-5.
[6] Link CL, Steers WD, Kusek JW, McKinlay JB. The association of adiposity and overactive bladder appears to differ by gender: results from the Boston Area Community Health Survey. J Urol 2011; 185: 955-63.
[7] Amarenco G, Serikoff A, Chartier-Kastler E, Grise P, Fatton B, Bruyère F, et al. Metabolic syndrome and urinary disorders. Prog Urol 2012; 22: 207-13.
[8] Klemper P, Amerenco G, Freeman R, Frontoni S, Horowitz M, Steven M et al. Management strategies for gastrointestinal erectile, bladders, and sudomotor dysfunction in patient with diabete. Diabetes, Mtab Res Rev 2011; 27: 665-77.
[9] Kadlec AO, Greco K, Fridirici Z C, Hart ST, Vellos T, Turk TM. Metabolic syndrome and urinary stone composition. Urology 2012; 84 (4): 805-10.
[10] Tai HC, Chung SD, Ho CH, Tai TY, Yang WS, Tseng CH, et al. Metabolic syndrome components worsen lower urinary tract symptoms in women with type 2 diabetes. J Clin Endocrinol Metab 2010; 95: 1143-50.
[11] Danforth KN, Townsend MK, Curhan GC, Resnick NM, Grodstein F. Type 2 diabetes mellitus and risk of stress, urge and mixed urinary incontinence. J Urol 2009; 181: 193-7.
[12] Zhu L, Lang J, Wang H, Han S, Huang J. The prevalence of and potential risk factors for female urinary incontinence in Beijing. China Menopause 2008;15: 566-9.
[13] Zhu L, Lang J, Liu C, Han S, Huang J, Li X. The epidemiological study of women with urinary incontinence and risk factors for stress urinary incontinence in China. Menopause 2009;16: 831-6.
[14] Boudokhane S, Marmouche H, Klii R, Jellad A, Mahjoub S, Ben Salah Frih Z. Troubles vésicosphinctériens et syndrome métabolique : étude prospective. Progrès en urologie 2013 23, 256-261.
[15] Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler 2005, Throm 2005; 12: 295-300.
[16] Tai HC, Chung SD, Ho CH, Tai TY, Yang WS, Tseng CH, et al. Metabolic syndrome components worsen lower urinary tract symptoms in women with type 2 diabetes. J Clin Endocrinol Metab 2010;95:1143—50.
[17] Milsom I, Abrams P, Cardozo L, et al. How widespread are the symptoms of an overactive bladder and how are they managed?A population-based prevalence study. BJU Int. 2001;87:760-766.
[18] Stewart W, Herzog R, Wein A, et al. Prevalence and impact of overactive bladder in the US: results from the NOBLE program. Neurourol Urodyn. 2001; 20:403-422.
[19] Kenjl Ohgaki, Kazutaka Horiuchi, and Yukihiro Kondo. Association Between Metabolic Syndrome and Male Overactive Bladder in a Japanese. Population Based on Three Different Sets ofCriteria for Metabolic Syndrome and the Overactive Bladder Symptom Score. Urology 2012; 79: 1372–1378.
[20] Rahman NU, Phonsombat S, Bochinski D, et al. An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat. BJU Int. 2007; 100: 658-663.
[21] Shen J, Tanida M, Niijima A, et al. In vivo effects of leptin on autonomic nerve activity and lipolysis in rats. Neurosci Lett 2007;416:193—7.
[22] Dallosso HM, McGrother CW, Matthews RJ, et al. The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. BJU Int 2003;92:69—77.
[23] Rohrmann S, Platz EA, Giovannucci E. Lifestyle and benign prostatic hyperplasia in older men: what do we know? J Men’s Health Gender 2005;2:230—9.
[24] Waring JV, Wendt IR. Effects of streptozotocin- induced diabetes mellitus on intracellular calcium and contraction of longitudinal smooth muscle from rat urinary bladder. J Urol 2000;63:323—30.
[25] Pitre DA, Ma T, Wallace LJ, Bauer JA. Time-dependent urinary bladder remodeling in the streptozotocin-induced diabetic rat model. Acta Diabetol 2002;39:23—7.
[26] Milsom I, Abrams P, Cardozo L, et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001; 87: 760-766.
[27] Stewart W, Herzog R, Wein A, et al. Prevalence and impact of overactive bladder in the US: results from the NOBLE program. Neurourol Urodyn. 2001; 20: 403-422.
[28] Chartier Kastler E, Leger D, Montauban V, Comet D, Haab F. Etude observationnelle nationale (Association Francaise d’Urologie) de l’impact de la nycturie sur le sommeil des patients porteur d’une hyperplasie bénigne de la prostate. Progrès Urologie 2009 ; 19 (5) 333-40.
[29] Kupelian V, Wei J T, O’Leary MP, Norgard J P, Rosen R C, Mc Kinlay JB. Nocturia and quality of life : results from the Boston area community health survey. Eur urol 2012; 61 (1): 78-84.
Cite This Article
  • APA Style

    Diagne N. S., Nait Khachat A., Azanmasso H., Tchonda E., Belhai K., et al. (2014). Quality of Life and Urinary Disorders in Metabolic Syndrome. American Journal of Biomedical and Life Sciences, 2(4), 78-82. https://doi.org/10.11648/j.ajbls.20140204.13

    Copy | Download

    ACS Style

    Diagne N. S.; Nait Khachat A.; Azanmasso H.; Tchonda E.; Belhai K., et al. Quality of Life and Urinary Disorders in Metabolic Syndrome. Am. J. Biomed. Life Sci. 2014, 2(4), 78-82. doi: 10.11648/j.ajbls.20140204.13

    Copy | Download

    AMA Style

    Diagne N. S., Nait Khachat A., Azanmasso H., Tchonda E., Belhai K., et al. Quality of Life and Urinary Disorders in Metabolic Syndrome. Am J Biomed Life Sci. 2014;2(4):78-82. doi: 10.11648/j.ajbls.20140204.13

    Copy | Download

  • @article{10.11648/j.ajbls.20140204.13,
      author = {Diagne N. S. and Nait Khachat A. and Azanmasso H. and Tchonda E. and Belhai K. and Tahiri A. and Lmidmani F. and Diop A. G. and Ndiaye M M and El Fatimi A.},
      title = {Quality of Life and Urinary Disorders in Metabolic Syndrome},
      journal = {American Journal of Biomedical and Life Sciences},
      volume = {2},
      number = {4},
      pages = {78-82},
      doi = {10.11648/j.ajbls.20140204.13},
      url = {https://doi.org/10.11648/j.ajbls.20140204.13},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajbls.20140204.13},
      abstract = {Introduction: Risk factors of urinary disorders in metabolic syndrome are known. Effect of their association is poorly documented. Objectives: Determine the types of metabolic syndrome as a largest provider of urinary disorders and impact of these on the quality of life. Methodology: We conducted a cross-sectional, descriptive, analytical multicenter study from january to May 2013. It was done in three centers: the departments of Physical Medicine and endocrinology of university hospital Ibn Rochd of Casablanca and the Lions Club’s "Insulin bank" of Cotonou, Benin. All patients with metabolic syndrome were included. Metabolic syndrome was diagnosed for NCEP ATP III criteria. Variables such as demographic characteristics, metabolic syndrome, glycemia, triglyceridemia and HDL cholestrolemia were noted. Evaluation of Urinary disorder was conducted by Urinary Symptoms Profile scale (USP). Urinary Symptoms Profile scale has ten items. It accesses urinary incontinence, urge incontinence and dysuria. Evaluation of quality of life was conducted by SF Qualiveen Scale. SF Qualiveen evaluates bother with limitations, fears, feeling and frequency of limitations. Results: we included 68 patients. Women represented 82.2%. The mean of age was 54.43 years. Patients with diabetes represented 98.5%. The main types of metabolic syndrome were the following associations: diabetes, high blood pressure and obesity (19.1%); diabetes, high blood pressure and dyslipidemia (16.2%); diabetes, obesity and dyslipidemia (8.8%). Urinary disorders are reported in 51.5% of cases. The main urinary symptoms were overactive bladder (58.8%), urinary incontinence (32.4%) and dysuria (16.2%). Overactive bladder was found in 64.28% of women and in 50% of men. Forty seven point thirty six percent (47.36%) of patients with diabetic neuropathy have manifested dysuria. The average score of USP was 8+/- 8.8. The average score of Qualiveen was 1.25. Metabolic syndrome is significantly associated to urinary disorders, especially the types diabetes-obesity-dyslipidemia (p=0.004) and diabetes-obesity- high blood pressure (HBP) p=0.001). Discussion: Urinary disorders in metabolic syndrome are dominated for overactive bladder. Overactive bladder is more frequent in women and patients aged less than 40 years. Risk factors of urinary disorder are diabetes and obesity. In metabolic syndrome, quality of life is impaired in patients with urinary disorders. Conclusion: Metabolic syndrome, especially the associations diabetes-obesity and diabetes- high body circumference (HBC) to others items, increased risk of urinary disorders. Urinary symptoms in metabolic syndrome are dominated by overactive bladder. Overactive bladder is more frequent in women and patients aged less than 40 years. Dysuria is unusual in metabolic syndrome and it’s not always correlated to diabetic neuropathy. Quality of life is impaired in patients with urinary disorder.},
     year = {2014}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Quality of Life and Urinary Disorders in Metabolic Syndrome
    AU  - Diagne N. S.
    AU  - Nait Khachat A.
    AU  - Azanmasso H.
    AU  - Tchonda E.
    AU  - Belhai K.
    AU  - Tahiri A.
    AU  - Lmidmani F.
    AU  - Diop A. G.
    AU  - Ndiaye M M
    AU  - El Fatimi A.
    Y1  - 2014/08/20
    PY  - 2014
    N1  - https://doi.org/10.11648/j.ajbls.20140204.13
    DO  - 10.11648/j.ajbls.20140204.13
    T2  - American Journal of Biomedical and Life Sciences
    JF  - American Journal of Biomedical and Life Sciences
    JO  - American Journal of Biomedical and Life Sciences
    SP  - 78
    EP  - 82
    PB  - Science Publishing Group
    SN  - 2330-880X
    UR  - https://doi.org/10.11648/j.ajbls.20140204.13
    AB  - Introduction: Risk factors of urinary disorders in metabolic syndrome are known. Effect of their association is poorly documented. Objectives: Determine the types of metabolic syndrome as a largest provider of urinary disorders and impact of these on the quality of life. Methodology: We conducted a cross-sectional, descriptive, analytical multicenter study from january to May 2013. It was done in three centers: the departments of Physical Medicine and endocrinology of university hospital Ibn Rochd of Casablanca and the Lions Club’s "Insulin bank" of Cotonou, Benin. All patients with metabolic syndrome were included. Metabolic syndrome was diagnosed for NCEP ATP III criteria. Variables such as demographic characteristics, metabolic syndrome, glycemia, triglyceridemia and HDL cholestrolemia were noted. Evaluation of Urinary disorder was conducted by Urinary Symptoms Profile scale (USP). Urinary Symptoms Profile scale has ten items. It accesses urinary incontinence, urge incontinence and dysuria. Evaluation of quality of life was conducted by SF Qualiveen Scale. SF Qualiveen evaluates bother with limitations, fears, feeling and frequency of limitations. Results: we included 68 patients. Women represented 82.2%. The mean of age was 54.43 years. Patients with diabetes represented 98.5%. The main types of metabolic syndrome were the following associations: diabetes, high blood pressure and obesity (19.1%); diabetes, high blood pressure and dyslipidemia (16.2%); diabetes, obesity and dyslipidemia (8.8%). Urinary disorders are reported in 51.5% of cases. The main urinary symptoms were overactive bladder (58.8%), urinary incontinence (32.4%) and dysuria (16.2%). Overactive bladder was found in 64.28% of women and in 50% of men. Forty seven point thirty six percent (47.36%) of patients with diabetic neuropathy have manifested dysuria. The average score of USP was 8+/- 8.8. The average score of Qualiveen was 1.25. Metabolic syndrome is significantly associated to urinary disorders, especially the types diabetes-obesity-dyslipidemia (p=0.004) and diabetes-obesity- high blood pressure (HBP) p=0.001). Discussion: Urinary disorders in metabolic syndrome are dominated for overactive bladder. Overactive bladder is more frequent in women and patients aged less than 40 years. Risk factors of urinary disorder are diabetes and obesity. In metabolic syndrome, quality of life is impaired in patients with urinary disorders. Conclusion: Metabolic syndrome, especially the associations diabetes-obesity and diabetes- high body circumference (HBC) to others items, increased risk of urinary disorders. Urinary symptoms in metabolic syndrome are dominated by overactive bladder. Overactive bladder is more frequent in women and patients aged less than 40 years. Dysuria is unusual in metabolic syndrome and it’s not always correlated to diabetic neuropathy. Quality of life is impaired in patients with urinary disorder.
    VL  - 2
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Department of Physical Medicine and Rehabilitation, Ibn Rochd, Casablanca, Morocco

  • Department of Physical Medicine and Rehabilitation, Ibn Rochd, Casablanca, Morocco

  • Department of Physical Medicine and Rehabilitation, Ibn Rochd, Casablanca, Morocco

  • Department of Physical Medicine and Rehabilitation, Ibn Rochd, Casablanca, Morocco

  • Department of Endocrinology, Ibn Rochd, Casablanca, Morocco

  • Department of Physical Medicine and Rehabilitation, Ibn Rochd, Casablanca, Morocco

  • Department of Neurology, Fann, Dakar, Senegal

  • Department of Neurology, Fann, Dakar, Senegal

  • Department of Physical Medicine and Rehabilitation, Ibn Rochd, Casablanca, Morocco